Aisling Capital Iii Lp - Net Worth and Insider Trading
Aisling Capital Iii Lp Net Worth
The estimated net worth of Aisling Capital Iii Lp is at least $479 Million dollars as of 2024-11-07. Aisling Capital Iii Lp is the 10% Owner of Loxo Oncology Inc and owns about 2,038,920 shares of Loxo Oncology Inc (LOXO) stock worth over $478 Million. Aisling Capital Iii Lp is the 10% Owner of Syros Pharmaceuticals Inc and owns about 90,857 shares of Syros Pharmaceuticals Inc (SYRS) stock worth over $232,594. Aisling Capital Iii Lp is also the 10% Owner of T2 Biosystems Inc and owns about 28,310 shares of T2 Biosystems Inc (TTOO) stock worth over $20,771. Besides these, Aisling Capital Iii Lp also holds Agile Therapeutics Inc (AGRX) . Details can be seen in Aisling Capital Iii Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aisling Capital Iii Lp has not made any transactions after 2018-07-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aisling Capital Iii Lp
Aisling Capital Iii Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aisling Capital Iii Lp owns 7 companies in total, including Loxo Oncology Inc (LOXO) , Syros Pharmaceuticals Inc (SYRS) , and Agile Therapeutics Inc (AGRX) among others .
Click here to see the complete history of Aisling Capital Iii Lp’s form 4 insider trades.
Insider Ownership Summary of Aisling Capital Iii Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LOXO | Loxo Oncology Inc | 2018-07-10 | 10 percent owner |
| SYRS | Syros Pharmaceuticals Inc | 2016-07-06 | 10 percent owner |
| AGRX | Agile Therapeutics Inc | 2014-05-23 | director & 10 percent owner |
 | | 2013-12-06 | 10 percent owner |
| | 2015-12-09 | 10 percent owner |
| | 2015-01-27 | 10 percent owner |
| | 2014-01-23 | 10 percent owner |
Aisling Capital Iii Lp Latest Holdings Summary
Aisling Capital Iii Lp currently owns a total of 4 stocks. Among these stocks, Aisling Capital Iii Lp owns 2,038,920 shares of Loxo Oncology Inc (LOXO) as of July 10, 2018, with a value of $478 Million and a weighting of 99.95%. Aisling Capital Iii Lp owns 90,857 shares of Syros Pharmaceuticals Inc (SYRS) as of July 6, 2016, with a value of $232,594 and a weighting of 0.05%. Aisling Capital Iii Lp also owns 28,310 shares of T2 Biosystems Inc (TTOO) as of December 9, 2015, with a value of $20,771 and a weighting of 0%. The other 1 stocks Agile Therapeutics Inc (AGRX) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Aisling Capital Iii Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LOXO | Loxo Oncology Inc | 2018-07-10 | 2,038,920 | 234.66 | 478,452,967 |
| SYRS | Syros Pharmaceuticals Inc | 2016-07-06 | 90,857 | 2.56 | 232,594 |
| TTOO | T2 Biosystems Inc | 2015-12-09 | 28,310 | 0.73 | 20,771 |
| AGRX | Agile Therapeutics Inc | 2014-05-23 | 1,086 | 1.51 | 1,640 |
Holding Weightings of Aisling Capital Iii Lp
Aisling Capital Iii Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Aisling Capital Iii Lp has made a total of 0 transactions in Loxo Oncology Inc (LOXO) over the past 5 years. The most-recent trade in Loxo Oncology Inc is the sale of 1,400,000 shares on July 10, 2018, which brought Aisling Capital Iii Lp around $251 Million.
According to the SEC Form 4 filings, Aisling Capital Iii Lp has made a total of 0 transactions in Syros Pharmaceuticals Inc (SYRS) over the past 5 years. The most-recent trade in Syros Pharmaceuticals Inc is the acquisition of 40,000 shares on July 6, 2016, which cost Aisling Capital Iii Lp around $5 Million.
According to the SEC Form 4 filings, Aisling Capital Iii Lp has made a total of 0 transactions in T2 Biosystems Inc (TTOO) over the past 5 years. The most-recent trade in T2 Biosystems Inc is the acquisition of 3,077 shares on December 9, 2015, which cost Aisling Capital Iii Lp around $3 Million.
More details on Aisling Capital Iii Lp's insider transactions can be found in the Insider Trading History of Aisling Capital Iii Lp table.Insider Trading History of Aisling Capital Iii Lp
- 1
Aisling Capital Iii Lp Trading Performance
GuruFocus tracks the stock performance after each of Aisling Capital Iii Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aisling Capital Iii Lp is -13.12%. GuruFocus also compares Aisling Capital Iii Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Aisling Capital Iii Lp within 3 months outperforms 2 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Aisling Capital Iii Lp's insider trading performs compared to the benchmark.
Performance of Aisling Capital Iii Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.51 | | | | | |
| Relative Return to S&P 500(%) | -4.9 | | | | | |
Aisling Capital Iii Lp Ownership Network
Ownership Network List of Aisling Capital Iii Lp
Ownership Network Relation of Aisling Capital Iii Lp
Aisling Capital Iii Lp Owned Company Details
What does Loxo Oncology Inc do?
Who are the key executives at Loxo Oncology Inc?
Aisling Capital Iii Lp is the 10 percent owner of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .
Loxo Oncology Inc (LOXO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Loxo Oncology Inc Insider Transactions
Aisling Capital Iii Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Aisling Capital Iii Lp. You might contact Aisling Capital Iii Lp via mailing address: 888 Seventh Avenue, 30th Fl, New York Ny 10106.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
